Miscellaneous Reports

Arrowhead Releases New Report Assessing State of Personalized Medicine Market - read more -

New Reports & Conferences eNewsletter

Featured Report

Personalized Medicine 2010

Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies

The era of Personalized Medicine is set to revolutionize the healthcare industry. As our knowledge of genetics and molecular biology rapidly expands, a personalized approach to medical care is becoming increasingly important. Not only does this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets.

- read more -

Miscellaneous Reports

The Prescribing Data Restriction Program: Critical Assessment & Best Practices

Since the mid-1990s, pharma companies have devised their sales and marketing strategies based on Rx data. However, with the introduction of the AMA’s Prescribing Data Restriction Program (PDRP) opt-out program in July 2006, pharma companies need to evaluate the impact of PDRP violation, mediate their PDRP compliance strategies, and revisit their existing Sales Force Effectiveness (SFE) practices.

Evidence-Based Medicine: Current Use and Future Impact on Global Clinical and Reimbursement Practices

Evidence-based medicine is defined as an attempt to use standards from scientifically-collected evidence to improve medical practices by assessing risks and benefits of treatments and/or the lack of treatments.
Read more...